IP Library Granted Patent US 12,097,145
Granted Patent B2
US 12,097,145 · App. 17/127,584 · Granted Sep 24, 2024

Vented multi-dose ocular fluid delivery system

Inventors: Reynaldo Quintana (Menlo Park, CA); Yehuda Ivri (Newport Coast, CA); Daniel V. Palanker (Sunnyvale, CA)
Assignee: BAUSCH + LOMB IRELAND LIMITED
A61F9/0008A61J1/1443
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,097,145
App. No.
17/127,584
Granted
Sep 24, 2024
Kind
B2
Abstract

A device for delivery of a precise amount of pharmaceutical fluid to the eye is provided. The device includes an ampoule for storing a liquid and an aperture through which the liquid is discharged. The device further includes a vibrating membrane that includes a needle which protrudes from the membrane and extends to the aperture to form a needle valve. The needle valve provides hermetic closure of the aperture to enable preservative-free storage of the pharmaceutical fluid in the device. The system further includes an electromagnetic transducer to shift the membrane back and forth in order to discharge liquid through the nozzle. Finally, the system further includes a vent to permit air to enter the ampoule as fluid is ejected from the ampoule. Preferably this vent includes a filter to prevent ingress of microbes or other contaminants to the ampoule.

Claims (18)

1. An apparatus for delivering a fluid to an eye of a patient, the apparatus comprising:

a fluid package comprising a reservoir configured to hold a fluid, an aperture, and a needle configured to seal the aperture when fluid is not being ejected through the aperture;

wherein the fluid package comprises a resilient diaphragm configured to provide a mechanical force to hold a tip of the needle in engagement with the aperture when fluid is not being ejected through the aperture;

wherein the resilient diaphragm is connected to the needle;

an actuator configured to eject the fluid through the aperture by providing a mechanical vibration at least to the needle; and

a vent configured to allow air to enter the reservoir as fluid leaves the reservoir.

2. The apparatus of claim 1 , further comprising a particle filter configured to remove particles larger than 0.2 μm from air that enters the reservoir via the vent.

3. The apparatus of claim 1 , wherein the actuator includes an electromagnetic solenoid.

4. The apparatus of claim 1 , wherein the actuator includes a coin vibration motor.

5. The apparatus of claim 1 , wherein the fluid package comprises a resilient spring configured to provide an additional mechanical force to hold the tip of the needle in engagement with the aperture when fluid is not being ejected through the aperture.

6. The apparatus of claim 1 , wherein the apparatus is configured to deliver a dose volume of 10 μl or less.

7. The apparatus of claim 1 , wherein a diameter of the aperture is in a range between 200 μm and 600 μm.

8. The apparatus of claim 1 , wherein a velocity of fluid ejected from the aperture is in a range from 1 m/s to 10 m/s.

9. The apparatus of claim 1 , wherein an actuation pulse duration is 250 ms or less.

10. The apparatus of claim 1 , wherein a repetition rate of actuation pulses is in a range from 10 Hz to 500 Hz.

11. The apparatus of claim 1 , wherein the needle has a tip that engages with the aperture, and wherein the tip comprises an anti-microbial material.

12. The apparatus of claim 1 , wherein the aperture comprises an anti-microbial material.

13. The apparatus of claim 1 , wherein the aperture is in a front wall of the reservoir and wherein the diaphragm is in a rear wall of the reservoir.

Assignments (8)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (066694/0131) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065531/0583 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT AGREEMENT PREVIOUSLY RECORDED ON REEL 062116 FRAME 0917. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 10, 2023
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064237/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2022
From: KEDALION THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 062116/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2020
From: QUINTANA, REYNALDO; IVRI, YEHUDA; PALANKER, DANIEL V.
To: KEDALION THERAPEUTICS, INC.
Reel/Frame 054759/0787 →
Continuity (7)
Continuation In Part 16811879 · Mar 6, 2020
Provisional Application 63049582 · Jul 8, 2020
Provisional Application 63049110 · Jul 7, 2020
Provisional Application 63011800 · Apr 17, 2020
Provisional Application 62951903 · Dec 20, 2019
Provisional Application 62814773 · Mar 6, 2019
Related Publication 20210137732A1 · May 13, 2021
Cited By (1)
US 12,667,485